In a study comparing Hologic’s standard compression technology to the SmartCurve™ system
Results from Friedewald, SM, et al. “Breast cancer screening using tomosynthesis in combination with digital mammography.” JAMA 311.24 (2014): 2499-2507; a multi-site (13), non-randomized, historical control study of 454,000 screening mammograms investigating the initial impact of the introduction of the Hologic Selenia Dimensions on screening outcomes. Individual results may vary. The study found an average 41% increase and that 1.2 (95% CI: 0.8-1.6) additional invasive breast cancers per 1000 screening exams were found in women receiving combined 2D FFDM and 3D™ mammograms acquired with the Hologic 3D Mammography System versus women receiving 2D FFDM mammograms only
Zuckerman SP, Conant EF, Keller BM, et al. Implementation of Synthesized Two-dimensional Mammography in a Population-based Digital Breast Tomosynthesis Screening Program. Radiology. 2016 Dec;281(3):730-736
Skaane P, Bandos A, Eben EB, et al. Two-view digital breast tomosynthesis screening with synthetically reconstructed projection images: comparison with digital breast tomosynthesis with full-field digital mammographic images. Radiology. 2014 Jun;271(3):655-63.
Bernardi D, Macaskill P, Pellegrini M, et. al. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study. Lancet Oncol. 2016 Aug;17(8):1105-13.
Rafferty EA, Durand MA, Conant EF, et al. Breast Cancer Screening Using Tomosynthesis and Digital Mammography in Dense and Nondense Breasts. JAMA. 2016 Apr 26;315(16):1784-6
McDonald ES, Oustimov A, Weinstein SP, et al. Effectiveness of Digital Breast Tomosynthesis Compared With Digital Mammography: Outcomes Analysis From 3 Years of Breast Cancer Screening. JAMA Oncol. 2016 Jun 1;2(6):737-43
FDA submissions P080003, P080003/S001 P080003/S005
Compared to Hologic standard 3D™ imaging
Not available on new purchases of Selenia® Dimensions® systems
Hologic data on file, 2017
Feature is used in combination with SecurView DX diagnostic review workstation Focus tool in v9.0.1 and above
Bloomquist AK, Yaffe MJ, Pisano ED et. al. Quality control for digital mammography in the ACRIN DMIST trial: part I. Med Phys 2006MAN-03608 Revision 006, April 2018
Back to Top
The content of this site is reserved for Health Care Professionals only.
You are about to access medical systems information on the Hologic 3Dimensions™ Mammography System European Website. Product availability differs by region and country and is subject to varied regulatory requirements.